In the aftermath of the Dobbs v. Jackson Women’s Health Organization decision, important questions have emerged about the current legal and regulatory landscape surrounding patient access to drugs that have historically been...more
This Diagnosing Health Care episode looks at the adjustments to business operations and compliance programs that pharmaceutical and medical device companies need to consider as they launch new products during the ongoing...more
9/29/2020
/ Clinical Trials ,
Coronavirus/COVID-19 ,
Health Care Providers ,
Life Sciences ,
Manufacturer Liability ,
Medical Devices ,
Medical Supplies ,
Pharmaceutical Industry ,
Physicians ,
Prescription Drugs ,
Product Development Protocols ,
Research and Development